Synergy Pharmaceutical Appoints Gastroenterologist Dr. Gail Comer as CMO

Synergy Pharmaceuticals, a developer of gastrointestinal disorder and disease drugs, has announced its appointment of gastroenterologist Gail M. Comer, MD, as chief medical officer, according to a news release.

 

In this new position, Dr. Comer will be responsible for guiding Synergy's clinical programs. Her appointment becomes effective May 14.

 

"Dr. Comer is a tremendous addition to our management team, and I am very pleased to welcome her to Synergy," said Gary S. Jacob, PhD, president and CEO of Synergy Pharmaceuticals, in the release. "Dr. Comer has an extremely strong medical and academic background, along with extensive industry experience in clinical research."

 

Dr. Comer is a board-certified gastroenterologist and hepatologist. She has more than 14 years of experience in the pharmaceutical industry, having spent seven years at Abbott Laboratories, six years at Wyeth Research and most recently serving as senior director of the biotherapeutics research unit at Pfizer.

 

Synergy Pharmaceuticals is based in New York.

 

Related Articles on Gastroenterologists:

IL's NCH Medical Group Acquires Practice of Gastroenterologist Dr. Nikos Christopoulos

Gastroenterologist Dr. R. Fraser Stokes Writes Column on Colorectal Cancer Prevention for Local Publication

Gastroenterologist on the Move: Dr. Ramaswamaiah Chandrasekhara Joins Central Florida Health Care

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast